Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus
- PMID: 25656443
- DOI: 10.1007/s00296-015-3231-3
Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus
Abstract
Uveitis associated with juvenile idiopathic arthritis (JIA) typically involves the anterior chamber segment, follows an indolent chronic course, and presents a high rate of uveitic complications and a worse outcome as compared to other aetiologies of uveitis. Disease assessment, treatment, and outcome measures have not been standardized. Collaboration between pediatric rheumatologists and ophthalmologists is critical for effective management and prevention of morbidity, impaired vision, and irreparable visual loss. Although the Standardization of Uveitis Nomenclature Working Group recommendations have been a great advance to help clinicians to improve consistency in grading and reporting data, difficulties arise at the time of deciding the best treatment approach in the individual patient in routine daily practice. For this reason, recommendations for a systematized control and treatment strategies according to clinical characteristics and disease severity in children with JIA-related uveitis were developed by a panel of experts with special interest in uveitis associated with JIA. A clinical management algorithm organized in a stepwise regimen is here presented.
Similar articles
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.Arthritis Rheumatol. 2019 Jun;71(6):864-877. doi: 10.1002/art.40885. Epub 2019 Apr 25. Arthritis Rheumatol. 2019. PMID: 31021511 Free PMC article.
-
Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.Pediatr Rheumatol Online J. 2020 Mar 23;18(1):26. doi: 10.1186/s12969-020-0419-1. Pediatr Rheumatol Online J. 2020. PMID: 32293465 Free PMC article.
-
Management of JIA associated uveitis.Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101979. doi: 10.1016/j.berh.2024.101979. Epub 2024 Jul 23. Best Pract Res Clin Rheumatol. 2024. PMID: 39048481 Review.
-
Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.Rheumatology (Oxford). 2019 Jun 1;58(6):975-986. doi: 10.1093/rheumatology/key406. Rheumatology (Oxford). 2019. PMID: 30590748 Free PMC article.
-
Juvenile idiopathic arthritis-associated uveitis.Best Pract Res Clin Rheumatol. 2017 Aug;31(4):517-534. doi: 10.1016/j.berh.2018.01.002. Epub 2018 Feb 26. Best Pract Res Clin Rheumatol. 2017. PMID: 29773271 Review.
Cited by
-
Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review.Rheumatology (Oxford). 2021 Aug 2;60(8):3540-3552. doi: 10.1093/rheumatology/keab237. Rheumatology (Oxford). 2021. PMID: 33710321 Free PMC article.
-
Update on the management of uveitis in children: an overview for the clinician.Expert Rev Ophthalmol. 2019;14(4-5):211-218. doi: 10.1080/17469899.2019.1663731. Epub 2019 Sep 19. Expert Rev Ophthalmol. 2019. PMID: 32831897 Free PMC article.
-
Adalimumab for the treatment of refractory noninfectious paediatric uveitis.Int Ophthalmol. 2017 Jun;37(3):719-725. doi: 10.1007/s10792-016-0293-5. Epub 2016 Jul 18. Int Ophthalmol. 2017. PMID: 27432171
-
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.Arthritis Care Res (Hoboken). 2019 Apr;71(4):482-491. doi: 10.1002/acr.23610. Arthritis Care Res (Hoboken). 2019. PMID: 29806733 Free PMC article.
-
Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies.Ophthalmol Ther. 2021 Mar;10(1):193-200. doi: 10.1007/s40123-020-00328-9. Epub 2021 Jan 19. Ophthalmol Ther. 2021. PMID: 33464558 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical